title: Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen.
authors.forename: Bruno
authors.initials: B
authors.lastname: Nobili
authors.forename: Gabriele
authors.initials: G
authors.lastname: Rossi
authors.forename: Piero
authors.initials: P
authors.lastname: De Stefano
authors.forename: Marco
authors.initials: M
authors.lastname: Zecca
authors.forename: Giovanna
authors.initials: G
authors.lastname: Giorgiani
authors.forename: Silverio
authors.initials: S
authors.lastname: Perrotta
authors.forename: Anna
authors.initials: A
authors.lastname: Canazzio
authors.forename: Franco
authors.initials: F
authors.lastname: Locatelli
mesh_terms: D000963:Antimetabolites / Q000008:administration & dosage*; D002675:Child, Preschool; D036101:Cord Blood Stem Cell Transplantation; D019871:Dyskeratosis Congenita / Q000601:surgery*; D006801:Humans; D008297:Male; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D014740:Vidarabine / Q000008:administration & dosage* / Q000031:analogs & derivatives*
chemical_list: D000963:Antimetabolites; D014740:Vidarabine; C024352:fludarabine